Head-to-head · Cost-Efficiency Index
Ryze Rx vs Vea Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ryze Rx
Cost-first shoppers who want compounded GLP-1s plus a broad TRT and peptide menu on one platform.
Visit Ryze RxVea Health
Shoppers comfortable completing a full intake before seeing any price, in exchange for a broader microdosing menu.
Visit Vea HealthThe verdict
Ryze Rx and Vea Health tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Ryze Rx (ranked #364, a hair above #366) — Cost-first shoppers who want compounded GLP-1s plus a broad TRT and peptide menu on one platform. But Vea Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ryze Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ryze Rx | Vea Health |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | $199/mo (starting dose, 3 month plan, compounded) | Not disclosed |
| Tirzepatide / mo | $199/mo (starting dose, 3 month plan, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #364 | #366 |
Ryze Rx
54/100Where the value is
- Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
- Physician consultation, ongoing clinical support and discreet shipping included with each prescription
- Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
The tradeoffs
- Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
- Pharmacy partners not named - only 'US-licensed compounding pharmacies'
Vea Health
54/100Where the value is
- Verified LegitScript certification with a working checker link (seal ID 48955268)
- Offers a genuine microdosing tier for both semaglutide and tirzepatide alongside the standard dose
- Repeats the FDA compounded-medication disclaimer on every page, and states 'Provider approval required. Not all patients qualify' rather than implying automatic approval
The tradeoffs
- Zero pricing is published anywhere on the public site — the entire catalog is gated behind the intake quiz
- No compounding pharmacy is named anywhere; the site only says 'domestic, pharmacy-grade suppliers' and 'FDA-registered, cGMP-certified facilities'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.